Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

New allergies after cord blood transplantation.

Vaughan LA, Vu M, Sengsayadeth S, Lucid C, Clifton C, McCarty K, Hagaman D, Domm J, Kassim A, Chinratanalab W, Goodman S, Greer J, Frangoul H, Engelhardt BG, Jagasia M, Savani BN.

Cytotherapy. 2013 Oct;15(10):1259-65. doi: 10.1016/j.jcyt.2013.05.018.

PMID:
23993300
2.

Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation.

Uchino M, Ogawa Y, Uchino Y, Mori T, Okamoto S, Tsubota K.

Br J Ophthalmol. 2012 Jan;96(1):34-7. doi: 10.1136/bjophthalmol-2011-300514. Epub 2011 Nov 3.

PMID:
22053104
3.

Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.

Wang X, Liu H, Li L, Geng L, Ding K, Liu X, Tong J, Zhu W, Sun Z.

Eur J Haematol. 2012 Jan;88(1):39-45. doi: 10.1111/j.1600-0609.2011.01709.x. Epub 2011 Nov 15.

PMID:
21933279
4.

Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).

Cornetta K, Laughlin M, Carter S, Wall D, Weinthal J, Delaney C, Wagner J, Sweetman R, McCarthy P, Chao N.

Biol Blood Marrow Transplant. 2005 Feb;11(2):149-60.

5.

Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.

Mori T, Tanaka M, Kobayashi T, Ohashi K, Fujisawa S, Yokota A, Fujita H, Nakaseko C, Sakura T, Nannya Y, Takahashi S, Kanamori H, Kanda Y, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy.

Biol Blood Marrow Transplant. 2013 Mar;19(3):486-91. doi: 10.1016/j.bbmt.2012.12.007. Epub 2012 Dec 16.

6.

Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.

Kobayashi K, Maeda Y, Hara Y, Nishie-Kataoka M, Nishimori H, Sugiyama H, Namba N, Kubonishi S, Niiya M, Shinagawa K, Ikeda K, Tanimoto M.

Anticancer Res. 2009 May;29(5):1763-70.

7.

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.

Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA, Carlson K, Cornillon J, Diez-Martin JL, Gandemer V, Faraci M, Lindemans C, O'Meara A, Mialou V, Renard M, Sedlacek P, Sirvent A, Socié G, Sora F, Varotto S, Sanz J, Voswinkel J, Vora A, Yesilipek MA, Herr AL, Gluckman E, Farge D, Rocha V.

Blood. 2013 Feb 7;121(6):1059-64. doi: 10.1182/blood-2012-07-445965. Epub 2012 Dec 17.

8.

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.

Sanz J, Boluda JC, Martín C, González M, Ferrá C, Serrano D, de Heredia CD, Barrenetxea C, Martinez AM, Solano C, Sanz MA, Sanz GF; Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH).

Bone Marrow Transplant. 2012 Oct;47(10):1287-93. doi: 10.1038/bmt.2012.13. Epub 2012 Feb 13.

PMID:
22327127
9.

Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT.

Herr AL, Kabbara N, Bonfim CM, Teira P, Locatelli F, Tiedemann K, Lankester A, Jouet JP, Messina C, Bertrand Y, Díaz de Heredia C, Peters C, Chaves W, Nabhan SK, Ionescu I, Gluckman E, Rocha V.

Blood. 2010 Sep 16;116(11):1849-56. doi: 10.1182/blood-2010-02-271692. Epub 2010 Jun 10.

10.

Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.

Okada M, Fujimori Y, Misawa M, Kai S, Nakajima T, Okikawa Y, Satake A, Itoi H, Takatsuka H, Itsukuma T, Nishioka K, Tamaki H, Ikegame K, Hara H, Ogawa H.

Biol Blood Marrow Transplant. 2008 Aug;14(8):896-903. doi: 10.1016/j.bbmt.2008.05.020.

11.

Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.

Yamada MF, Miyamura K, Fujiwara T, Kohata K, Okitsu Y, Ohguchi H, Yamamoto J, Yokoyama H, Tomiya Y, Ishizawa K, Kameoka J, Harigae H.

Transplant Proc. 2008 Dec;40(10):3637-42. doi: 10.1016/j.transproceed.2008.06.102.

PMID:
19100456
12.

Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.

Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D.

Klin Padiatr. 2004 Nov-Dec;216(6):356-63.

PMID:
15565551
13.

Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies.

Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y, Yamada T, Uchimaru K, Tojo A, Shirafuji N, Kodo H, Tani K, Takahashi T, Yamaguchi T, Asano S.

Blood. 2004 Dec 1;104(12):3813-20. Epub 2004 Jul 27.

14.

[Unrelated cord blood transplantation for the treatment of hematological malignancies].

Ren HY, Zhang YC, Huang XJ, Xu LP, Liu KY, Li D, Guo NL, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2003 Feb;24(2):82-5. Chinese.

PMID:
12697102
15.

Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.

Le Bourgeois A, Mohr C, Guillaume T, Delaunay J, Malard F, Loirat M, Peterlin P, Blin N, Dubruille V, Mahe B, Gastinne T, Le Gouill S, Moreau P, Mohty M, Planche L, Lode L, Bene MC, Chevallier P.

Biol Blood Marrow Transplant. 2013 Jun;19(6):934-9. doi: 10.1016/j.bbmt.2013.03.009. Epub 2013 Mar 21.

16.

Unrelated cord blood transplantation after myeloablative conditioning regimen in adolescent and young adult patients with hematologic malignancies: a single institute analysis.

Ebihara Y, Takahashi S, Mochizuki S, Kato S, Kawakita T, Ooi J, Yokoyama K, Nagamura F, Tojo A, Asano S, Tsuji K.

Leuk Res. 2012 Feb;36(2):128-31. doi: 10.1016/j.leukres.2011.09.016. Epub 2011 Oct 5.

PMID:
21982638
17.

Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.

Mori T, Aisa Y, Nakazato T, Yamazaki R, Shimizu T, Mihara A, Yamane A, Ikeda Y, Okamoto S.

Transplant Proc. 2007 Jun;39(5):1615-9.

PMID:
17580201
18.

CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.

Mikulska M, Raiola AM, Bruzzi P, Varaldo R, Annunziata S, Lamparelli T, Frassoni F, Tedone E, Galano B, Bacigalupo A, Viscoli C.

Biol Blood Marrow Transplant. 2012 Jan;18(1):92-9. doi: 10.1016/j.bbmt.2011.05.015. Epub 2011 May 27.

19.

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen.

Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M, Fukuno K, Uchiyama M, Takasugi K, Iseki T, Tojo A, Yamaguchi T, Asano S.

Blood. 2007 Feb 1;109(3):1322-30. Epub 2006 Oct 12.

20.

High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults.

Takagi S, Masuoka K, Uchida N, Ishiwata K, Araoka H, Tsuji M, Yamamoto H, Kato D, Matsuhashi Y, Kusumi E, Ota Y, Seo S, Matsumura T, Matsuno N, Wake A, Miyakoshi S, Makino S, Ohashi K, Yoneyama A, Taniguchi S.

Br J Haematol. 2009 Nov;147(4):543-53. doi: 10.1111/j.1365-2141.2009.07863.x. Epub 2009 Aug 25.

PMID:
19709082

Supplemental Content

Support Center